Literature DB >> 3121249

LH-RH agonist treatment of endometriosis.

A Lemay1, R Maheux, G Quesnel, M Bureau, N Faure, P Mérat.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1987        PMID： 3121249

Source DB:  PubMed          Journal:  Contrib Gynecol Obstet        ISSN： 0304-4246


× No keyword cloud information.
  3 in total

Review 1.  Buserelin. A review of its pharmacodynamic and pharmacokinetic properties, and clinical profile.

Authors:  R N Brogden; M M Buckley; A Ward
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

2.  LH-RH agonist (buserelin): treatment of endometriosis. Clinical, laparoscopic, endocrine and metabolic evaluation.

Authors:  U Cirkel; K W Schweppe; H Ochs; J P Hanker; H P Schneider
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

3.  Long-term GnRH agonist therapy before in vitro fertilisation (IVF) for improving fertility outcomes in women with endometriosis.

Authors:  Ektoras X Georgiou; Pedro Melo; Philip E Baker; Hassan N Sallam; Aydin Arici; Juan A Garcia-Velasco; Ahmed M Abou-Setta; Christian Becker; Ingrid E Granne
Journal:  Cochrane Database Syst Rev       Date:  2019-11-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.